ArticleFrontiers in pharmacology2022

Elucidating type 2 diabetes mellitus risk factor by promoting lipid metabolism with gymnemagenin: An

Anusree DasNandy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.